Aimmune Therapeutics Files Registration Statement for Initial Public Offering by longitudeadmin | Jul 6, 2015 | Portfolio News
Collegium Expands Leadership Team With Vice President of Regulatory Affairs and Quality Assurance by longitudeadmin | Jul 1, 2015 | Portfolio News
Corcept Therapeutics Appoints Daniel Swisher to Board of Directors by longitudeadmin | Jun 22, 2015 | Portfolio News
Aimmune Therapeutics Receives FDA Breakthrough Therapy Designation for AR101 by longitudeadmin | Jun 18, 2015 | Portfolio News
